181 related articles for article (PubMed ID: 35245483)
61. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
Tani SM; Wang Y; Kanegane H; Futatani T; Pinto J; Vilela MM; Miyawaki T
Hum Mutat; 2002 Sep; 20(3):235-6. PubMed ID: 12204007
[TBL] [Abstract][Full Text] [Related]
62. Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.
Rawat A; Jindal AK; Suri D; Vignesh P; Gupta A; Saikia B; Minz RW; Banday AZ; Tyagi R; Arora K; Joshi V; Mondal S; Shandilya JK; Sharma M; Desai M; Taur P; Pandrowala A; Gowri V; Sawant-Desai S; Gupta M; Dalvi AD; Madkaikar M; Aggarwal A; Raj R; Uppuluri R; Bhattad S; Jayaram A; Lashkari HP; Rajasekhar L; Munirathnam D; Kalra M; Shukla A; Saka R; Sharma R; Garg R; Imai K; Nonoyama S; Ohara O; Lee PP; Chan KW; Lau YL; Singh S
Front Immunol; 2020; 11():612323. PubMed ID: 33584693
[TBL] [Abstract][Full Text] [Related]
63. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
64. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.
Futatani T; Watanabe C; Baba Y; Tsukada S; Ochs HD
Br J Haematol; 2001 Jul; 114(1):141-9. PubMed ID: 11472359
[TBL] [Abstract][Full Text] [Related]
65. B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.
Toker O; Broides A; Lev A; Simon AJ; Megged O; Shamriz O; Tal Y; Somech R; Lee YN; Nahum A
Immunol Res; 2022 Apr; 70(2):216-223. PubMed ID: 35001352
[TBL] [Abstract][Full Text] [Related]
66. Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report.
Srinivasan C; Shameli A; Ritchie B; Adatia A
Immun Inflamm Dis; 2023 Oct; 11(10):e1049. PubMed ID: 37904676
[TBL] [Abstract][Full Text] [Related]
67. Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults.
Usui K; Sasahara Y; Tazawa R; Hagiwara K; Tsukada S; Miyawaki T; Tsuchiya S; Nukiwa T
Respir Res; 2001; 2(3):188-92. PubMed ID: 11686883
[TBL] [Abstract][Full Text] [Related]
68. Mutations in Bruton's tyrosine kinase impair IgA responses.
Mitsuiki N; Yang X; Bartol SJ; Grosserichter-Wagener C; Kosaka Y; Takada H; Imai K; Kanegane H; Mizutani S; van der Burg M; van Zelm MC; Ohara O; Morio T
Int J Hematol; 2015 Mar; 101(3):305-13. PubMed ID: 25589397
[TBL] [Abstract][Full Text] [Related]
69. Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia.
Vu QV; Wada T; Le HT; Le HT; Van Nguyen AT; Osamu O; Yachie A; Nguyen SN
BMC Pediatr; 2014 May; 14():129. PubMed ID: 24885015
[TBL] [Abstract][Full Text] [Related]
70. A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male.
Kornfeld SJ; Haire RN; Strong SJ; Tang H; Sung SS; Fu SM; Litman GW
Mol Med; 1996 Sep; 2(5):619-23. PubMed ID: 8898377
[TBL] [Abstract][Full Text] [Related]
71. Maternal germinal mosaicism of X-linked agammaglobulinemia.
Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N
Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495
[TBL] [Abstract][Full Text] [Related]
72. A new mutation that predicted a drastic alteration of the BTK protein function.
Debost-Legrand A; Legrand G; Moulillot G; Francannet C; Bocly B; Theodoroub I; Paillard C
Gene; 2013 Sep; 527(1):426-8. PubMed ID: 23774691
[TBL] [Abstract][Full Text] [Related]
73. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
[TBL] [Abstract][Full Text] [Related]
74. Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia.
Wang Y; Kanegane H; Sanal O; Ersoy F; Tezcan I; Futatani T; Tsukada S; Miyawaki T
Hum Mutat; 2001 Oct; 18(4):356. PubMed ID: 11668622
[TBL] [Abstract][Full Text] [Related]
75. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
[TBL] [Abstract][Full Text] [Related]
76. Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report.
Li M; Chen W; Sun X; Wang Z; Zou X; Wei H; Wang Z; Chen W
BMC Med Genet; 2019 Sep; 20(1):157. PubMed ID: 31510946
[TBL] [Abstract][Full Text] [Related]
77. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
[TBL] [Abstract][Full Text] [Related]
78. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
79. Agammaglobulinemia: from X-linked to Autosomal Forms of Disease.
Cardenas-Morales M; Hernandez-Trujillo VP
Clin Rev Allergy Immunol; 2022 Aug; 63(1):22-35. PubMed ID: 34241796
[TBL] [Abstract][Full Text] [Related]
80. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
Schuster V; Seidenspinner S; Kreth HW
Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
